Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic phenotype. Some 20% to 40% of COPD patients have elevated blood eosinophil counts ...
Dedicated COPD respiratory therapists can improve inhaler use, ensure adherence, and bridge care transitions, explained Megan ...
Rising awareness of sleep-related breathing disorders, advanced home care adoption, and improved diagnostic infrastructure are driving market expansion across major regions.Austin, Oct. 22, 2025 ...
Ensifentrine significantly improved lung function after 12 weeks in patients with moderate to severe COPD with and without ...
Most patients with persistent pulmonary symptoms after recovering from mild to moderate COVID-19 infection have normal ...
This approach offers an excellent negative predictive value.1 However, its specificity is poor and there is an increasing ...
Abstract: The fusion of multimodal medical data is crucial for helping doctors make accurate treatment decisions. For example, combining Computed Tomography Pulmonary Angiography (CTPA) with ...
GameSpot may get a commission from retail offers. The Battlefield franchise has always been known for its high-quality graphics, and Battlefield 6 is no different. At the launch of Battlefield 6, the ...
Expedition Therapeutics has closed a $165 million series A financing, just two months after acquiring global rights outside China to its lead candidate from Shanghai Fosun Pharmaceutical. The round ...
Diego is a writer and editor with over six years of experience covering games. He's mainly focused on guides, but he's done reviews, features, news, and everything in between. A fan of all genres, you ...
The approval is the first in more than a decade for an idiopathic pulmonary fibrosis treatment. The FDA has approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback